Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First Allografts
Open Access
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (10) , 1314-1322
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experienceBritish Journal of Haematology, 2008
- Long-Term Follow-Up of Patients Who Experienced Graft Failure Postallogeneic Progenitor Cell Transplantation. Results of a Single Institution AnalysisTransplantation and Cellular Therapy, 2008
- PDGF, TGF-β, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineagesBlood, 2008
- Reduced-Intensity Conditioning followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Myelodysplastic Syndrome and Myeloproliferative DisordersTransplantation and Cellular Therapy, 2008
- Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejectionBone Marrow Transplantation, 2007
- Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantationBone Marrow Transplantation, 2007
- Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential ThrombocythemiaTransplantation and Cellular Therapy, 2007
- HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignanciesBlood, 2003
- Radiobiological speculations on therapeutic total body irradiationCritical Reviews in Oncology/Hematology, 1990
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986